Allergan, Inc'

1
Allergan, Inc.

• Presented by
• Vince Brown
• Washington Kadzombe
• Antoinette Morales
• Larissa Sanchez
• Willie Stevens
• Paul Sucgang
• ECO 533
• October 23, 2002

2
Company History

• 1950 Company Established
• 1960s Allergan Nasal Drops
• 1970s Publicly Traded
• 1980s Botox Developed
• 2000s FDA Approval April 2002
• Shareholders

3
Product

• Botox Cosmetic
• Characteristics
• What is it?
• Approvals
• Growth

4
Production

• Production Technique
• Growth of Culture
• Harvesting Toxins
• Purification
• Packaging

5
Production
6
Production

• Cutting Costs
• Accelerated Culture Growth
• Cutting Waste
• Cross Training
• Employee Retention

7
Competition

• Medical vs. Cosmetic
• Market Share

8
Competition

• Medical
• Substitutes
• Plastic Surgery (500 and Up)
• Myobloc (Future Competitor)
• Botulinum Toxin Type B
• Still in Clinical Trials

9
Competition

• Cosmetic (Less Expensive)
• Substitutes
• Lancome or Oil of Olay
• DuoMasque (40)
• Wrinkle-Lite Face Cream (25)
• Hollywood Wrinkle Face Cream (39)
• Ceramide-C Skin Therapy Capsule (70)

10
Financials

• Gearing Ratio
• Solvency Ratio
• Return on Capital

11
Break-Even Analysis

• Break-Even Point
• Break-Even Units
• Unit Variable Cost
• Fixed Cost

12
Economic Forecasts

• Demographics
• Aging Society
• Changing Face of America
• Areas of Impact
• Shift in Economic And Political Power

13
Economic Forecasts

• Interest Rate Changes
• Reaction From Current Rate (4.75)
• Results From Rate Increase
• Results From Rate Decline

14
Economic Forecasts

• Technology
• Advances Towards Safer Product
• Product Line Expansion
• More Information for Doctors Patients
• Reduction in Manufacturing/Production Cost
• Stable Cost for Users

15
The New Economy

• Old vs. New
• Technology
• Employee Involvement
• Customer Service

16
Conclusion

• Botox Cosmetic
• Competitors
• Solid Financially
• Aging Population
• New Economy

17
(No Transcript)